These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35118932)

  • 1. Computational studies on the cholinesterase, beta-secretase 1 (BACE1) and monoamine oxidase (MAO) inhibitory activities of endophytes-derived compounds: towards discovery of novel neurotherapeutics.
    Falade AO; Adewole KE; Ishola AA; Gyebi GA; Olajide NR
    J Biomol Struct Dyn; 2023 Apr; 41(6):2540-2554. PubMed ID: 35118932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential inhibitors of cholinergic and β-secretase enzymes from phytochemicals derived from Gongronema latifolium Benth leaf: an integrated computational analysis.
    Gyebi GA; Ogunyemi OM; Ibrahim IM; Ogunro OB; Afolabi SO; Ojo RJ; Anyanwu GO; El-Saber Batiha G; Adebayo JO
    Mol Divers; 2024 Jun; 28(3):1305-1322. PubMed ID: 37338673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
    Jannat S; Balupuri A; Ali MY; Hong SS; Choi CW; Choi YH; Ku JM; Kim WJ; Leem JY; Kim JE; Shrestha AC; Ham HN; Lee KH; Kim DM; Kang NS; Park GH
    Exp Mol Med; 2019 Feb; 51(2):1-18. PubMed ID: 30755593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones.
    Lee S; Youn K; Lim G; Lee J; Jun M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29932100
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ayaz M; Wadood A; Sadiq A; Ullah F; Anichkina O; Ghufran M
    J Biomol Struct Dyn; 2022; 40(20):10230-10238. PubMed ID: 34157942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytochemicals-based β-amyloid cleaving enzyme-1 and MAO-B inhibitors for the treatment of Alzheimer's disease: molecular simulations-based predictions.
    Mahnashi MH; Ayaz M; Ghufran M; Almazni IA; Alqahtani O; Alyami BA; Alqahtani YS; Khan HA; Sadiq A; Waqas M
    J Biomol Struct Dyn; 2024 Oct; 42(16):8359-8371. PubMed ID: 37815007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
    J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer's Treatment: A Computational Strategy.
    Jabir NR; Rehman MT; Tabrez S; Alserihi RF; AlAjmi MF; Khan MS; Husain FM; Ahmed BA
    Curr Pharm Des; 2021; 27(20):2425-2434. PubMed ID: 33634754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors.
    Bhakta HK; Park CH; Yokozawa T; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2016 Jun; 39(6):794-805. PubMed ID: 27106028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking and molecular dynamics approach to identify potential compounds in
    Tung BT; Hang TTT; Kim NB; Nhung NH; Linh VK; Thu DK
    J Complement Integr Med; 2022 Dec; 19(4):955-965. PubMed ID: 35621378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
    Nuthakki VK; Yadav Bheemanaboina RR; Bharate SB
    Bioorg Chem; 2021 Feb; 107():104568. PubMed ID: 33418314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
    Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
    Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease.
    Matošević A; Opsenica DM; Spasić M; Maraković N; Zandona A; Žunec S; Bartolić M; Kovarik Z; Bosak A
    Chem Biol Interact; 2023 Sep; 382():110620. PubMed ID: 37406982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of BACE1, MAO-B, cholinesterase enzymes, and anti-amyloidogenic potential of selected natural phytoconstituents: Multi-target-directed ligand approach.
    Chowdhury S; Kumar S
    J Food Biochem; 2021 Jan; 45(1):e13571. PubMed ID: 33249607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases.
    Vishnu MS; Pavankumar V; Kumar S; Raja AS
    ChemMedChem; 2019 Jul; 14(14):1359-1376. PubMed ID: 31177620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors.
    Osmaniye D; Evren AE; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100450. PubMed ID: 34931332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors.
    Basri R; Fatima S; Jalil S; Imran A; Fatima N; Syed A; Bahkali AH; Iqbal J; Shafiq Z
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300430. PubMed ID: 37718357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of the 4-Substituted 2-Hydroxy-5-Iodochalcones and Their 7-Substituted 6-Iodoflavonol Derivatives for Inhibitory Effect on Cholinesterases and β-Secretase.
    Mphahlele MJ; Agbo EN; Gildenhuys S
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.